Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1982 | 12-1981 | |
| Assets | ||
| Current Assets | ||
| Other current assets | 3 | 13 |
| TOTAL | $3 | $13 |
| Non-Current Assets | ||
| PPE Net | 414 | N/A |
| TOTAL | $414 | $N/A |
| Total Assets | $416 | $13 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 67 | 15 |
| Accrued Expenses | 50 | 49 |
| Other current liabilities | 0 | 85 |
| TOTAL | $118 | $149 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $118 | $149 |
| Shareholders' Equity | ||
| Common Shares | 38 | 38 |
| TOTAL | $2,362 | $62 |
| Total Liabilities And Equity | $2,480 | $211 |